The forthcoming study is supported by the Path towards Personalized Medicine (PPM) program of QNRF (PPM2-0207-170010 - Identification of genetic variants associated with polycystic ovary
Syndrome (PCOS) is a widespread reproductive disorder described by hyperandrogenism, polycystic ovaries, and anovulation (1).
Induction of polycystic ovary
by testosterone in immature female rats: Modulation of apoptosis and attenuation of glucose/insulin ratio.
Table-1: Clinical data at baseline and at 3-and 12-week supervised aerobic training follow-ups of obese women with or without polycystic ovary
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary
syndrome: A systematic review and meta-analysis.
Insulin Resistance in Women with Polycystic Ovary
Syndrome: Optimizing treatment by implementing an in vitro Insulin Resistance Organ Culture Model.
The Androgen Excess and PCOS Society criteria for the polycystic ovary
syndrome: the complete task force report.
Diamandi-Candarakis, "Policistic ovary syndrome: definitions, phenotipes and diagnostic approach," in Polycystic Ovary
INTRODUCTION: Polycystic ovary
syndrome (PCOS), is a complex disease also called hyperandrogenic anovulation (HA), or Stein-Leventhal syndrome, is one of the most common endocrine disorders among women.
One hundred seventy women (mean age, 25 years) with clomiphene-resistant polycystic ovary
A / Treatment of polycystic ovary
syndrome (PCOS) in women not actively seeking to become pregnant is symptom-specific.